Piramal Pharma Limited (NSE:PPLPHARMA)
India
· Delayed Price · Currency is INR 202.83
+1.84 (0.92%)
Jun 27, 2025, 3:29 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 257.04 billion as of June 27, 2025. Its market cap has increased by 29.25% in one year.
Market Cap
257.04B
Enterprise Value
300.39B
Revenue
91.51B
Ranking
n/a
PE Ratio
284.37
Stock Price
202.83
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 257.04B, an increase of 13.37%. That is a compound annual growth rate of 4.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 267.17B | -24.31% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,005.93B |
| Divi's Laboratories | 1,742.93B |
| Cipla | 1,213.50B |
| Apollo Hospitals Enterprise | 1,007.36B |
| Zydus Lifesciences | 970.56B |
| Mankind Pharma | 952.37B |
| Aurobindo Pharma | 641.32B |
| Fortis Healthcare | 588.72B |